The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Finch Therapeutics Group, Inc(NASDAQ:FNCH) 
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that has completed Phase II clinical trial for the t...
Share this website to your friends
Finch Therapeutics Group Days Payable Outstanding ttm (DPO)
Finch Therapeutics Group Days Receivable Outstanding ttm (DSO)
Finch Therapeutics Group Op Cashflow Per Share ttm
Finch Therapeutics Group Free Cashflow Per Share ttm
Finch Therapeutics Group Cash Per Share ttm
Finch Therapeutics Group P/S ratio ttm
Finch Therapeutics Group (GAAP) P/E ratio ttm
Finch Therapeutics Group P/B ratio ttm
No extra charts and metrics for this ticker.